Physician profile
Emma Liegh Walker
NPI 1639796196
$1,355.87
in general payments reported to CMS, 2019-2025
14 companies · $459 in 2025
The $459 reported for 2025 was more than what 82% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $58.65 · 2023: $396 · 2024: $261 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $323.03 | 2021-2025 | Breztri, Airsupra |
| Sumitomo Pharma America, INC. | $204.49 | 2023-2025 | Gemtesa |
| Gilead Sciences, INC. | $186.69 | 2024-2025 | Epclusa |
| Corcept Therapeutics | $121.60 | 2025 | Korlym |
| Exact Sciences Corporation | $76.46 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $72.95 | 2023-2024 | |
| Abbvie INC. | $71.33 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.65 | 2022 | |
| Inari Medical, INC. | $51.70 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $45.47 | 2024 | Xarelto |
| Lilly USA, LLC | $29.74 | 2021 | |
| Merck Sharp & Dohme LLC | $21.97 | 2023 | Verquvo |
| Smith+Nephew, INC. | $17.00 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.